0
Title
User
LIVE NOW
LIVE NOW
Title
User
Sign In
Home
Trending
Sign In
Audios and Videos
Videos
Audios
Channels
Browse Channels
Categories
Acute Lymphoblastic Leukemia
5643
Acute Myelogenous Leukemia
153
Bladder Cancer
51
Bone Metastases
1
Brain Cancer
23
Breast Cancer
130
Business Management
2
Cervical Cancer
2
Chronic Lymphocytic Leukemia
163
Chronic Myelogenous Leukemia
23
Colorectal Cancer
75
Gastrointestinal Cancer
71
General
251
Head and Neck Cancers
35
Hematologic Malignancies
82
Hodgkin Lymphoma
19
Immunotherapy
95
Kidney Cancer
365
Liver Cancer
11
Lymphoma
145
Melanoma and Skin Cancer
51
Multiple Myeloma
353
Myeloproliferative Disease
17
News
128
Non-Hodgkin Lymphoma
52
Non-Small Cell Lung Cancer
266
Other
112
Ovarian Cancer
10
Pancreatic Cancer
55
Patient Resources
27
Prostate Cancer
152
Small Cell Lung Cancer
59
Soft Tissue Sarcoma
9
Supportive Care
40
Testicular Cancer
2
Urology
9
Uterine Cancer
2
About
Contact
PharmaMar
Subscribe
0
My videos
0:04:01
Pascal Besman, COO Pharmamar - PharmaMar to submit New Drug Application (NDA) for lurbinectedin
Pascal Besman, COO Pharmamar - PharmaMar to submit New Drug Application (NDA) for lurbinectedin under accelerated approval in SCLC in the USA. Pascal Besman, Pharmamar COO discusses advantages and potential limitations of the new drug.
Small Cell Lung Cancer
64 Views
5 months ago
PharmaMar
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
0:02:13
Taofeek Owonikoko MD, PhD, MSCR - Lurbinectedin, a potential practice changing drug if approved
Small Cell Lung Cancer
43 Views
5 months ago
PharmaMar
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
0:07:54
Hossein Borghaei, DO, MS - New Drug Application (NDA) for lurbinectedin
Small Cell Lung Cancer
57 Views
5 months ago
PharmaMar
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
00:29:12
Spanish Version - Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial
Small Cell Lung Cancer
426 Views
7 months ago
PharmaMar
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
00:28:53
Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial
Small Cell Lung Cancer
871 Views
7 months ago
PharmaMar
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
00:00:28
Luis G. Paz-Ares, MD, PHD Special Presentation June 1st, 2019 McCormick Place Hall D2, 3pm
Small Cell Lung Cancer
577 Views
8 months ago
PharmaMar
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
